Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(48 sites)
United States
UCSD Moores Cancer Center, La Jolla, California USC Norris Comprehensive Cancer Center, Los Angeles, California University of Colorado Cancer Center, Aurora, Colorado University of Miami, Miami, Florida Comprehensive Hematology Oncology, St. Petersburg, Florida University of Chicago, Chicago, Illinois Massachusetts General Hospital, Boston, Massachusetts Dana Farber Cancer Institute, Boston, Massachusetts University of Michigan, Ann Arbor, Michigan Henry Ford Cancer Institute, Detroit, Michigan START - Midwest Cancer Research Center, Grand Rapids, Michigan Saint Luke's Cancer Institute, Kansas City, Missouri Washington University School of Medicine, St Louis, Missouri RUTGERS Cancer Institute, New Brunswick, New Jersey Icahn School of Medicine at Mount Sinai, New York, New York Duke Cancer Institute, Durham, North Carolina University Hospital Cleveland Medical Center, Cleveland, Ohio Cleveland Clinic, Cleveland, Ohio OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma Providence Cancer Institute, Portland, Oregon SCRI Oncology Partners, Nashville, Tennessee Vanderbilt Ingram Cancer Center, Nashville, Tennessee NEXT Oncology - Austin, Austin, Texas NEXT Oncology - Dallas, Dallas, Texas Mary Crowley Cancer Research, Dallas, Texas MD Anderson Cancer Center - University of Texas, Houston, Texas START Mountain Region, West Valley City, Utah NEXT Oncology - Virginia Cancer Specialists, Fairfax, Virginia Fred Hutchinson Cancer Center, Seattle, Washington France
Centre Georges François Leclerc, Dijon Institut de Cancerologie de l'Ouest, Saint-Herblain Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole Institut Claudius Regaud ", Toulouse Ireland
The START center Dublin, Dublin, Dublin Cork University Hospital, Wilton, Cork St. Vincent's University Hospital, Dublin Italy
Azienda Ospedaliero Universitaria Careggi - Largo Giovanni Alessandro Brambilla 3, Florence Istituto Europeo di Oncologia (IEO), Milan Netherlands
Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam South Korea
Seoul National University Hospital, Seoul Severance Hospital - Yonsei Cancer Center, Seoul Asan Medical Center, Seoul Samsung Medical Center, Seoul Spain
Hospital Universitario Vall dHebron, Barcelona Hospital Universitario 12 de Octubre, Madrid START Madrid CIOCC, Hospital Universitario HM Sanchinarro, Madrid Hospital Universitario Virgen del Rocio, Seville Hospital Clinico Universitario de Valencia (INCLIVA), Valencia United Kingdom
Oxford University Hospitals NHS Foundation Trust Churchill Hospital, Oxford